Anticoagulants, Antiplatelets, and Statins in Heart Failure

Dimitrios Farmakis, Gerasimos Filippatos, Mitja Lainscak, John T. Parissis, Stefan D. Anker, Dimitrios T. Kremastinos

Research output: Contribution to journalArticlepeer-review

Abstract

The existing guidelines for the treatment of patients who have heart failure limit the administration of antiplatelet and anticoagulant agents to patients who have specific comorbidities, including coronary artery disease, atrial fibrillation, history of thromboembolic events, and left ventricular mural thrombus. Retrospective analyses of large clinical trials or smaller nonrandomized studies indicate that the use of statins may be beneficial both in ischemic and idiopathic dilated cardiomyopathy. This article outlines the current knowledge regarding the use of antiplatelet and anticoagulant agents and statins in patients who have heart failure.

Original languageEnglish
Pages (from-to)49-58
Number of pages10
JournalCardiology Clinics
Volume26
Issue number1
DOIs
Publication statusPublished - Feb 2008

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Anticoagulants, Antiplatelets, and Statins in Heart Failure'. Together they form a unique fingerprint.

Cite this